CASI Pharmaceuticals Inc. (NASDAQ: CASI)
$6.17
-0.0800 ( -1.28% ) 41.2K
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
Market Data
Open
$6.17
Previous close
$6.25
Volume
41.2K
Market cap
$85.23M
Day range
$5.91 - $6.30
52 week range
$1.90 - $8.48
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Jul 08, 2024 |
6-k | Quarterly Reports | 3 | Jun 27, 2024 |
6-k | Quarterly Reports | 3 | Jun 27, 2024 |
6-k | Quarterly Reports | 3 | May 15, 2024 |
6-k | Quarterly Reports | 1 | Apr 08, 2024 |
6-k | Quarterly Reports | 3 | Mar 28, 2024 |
20-f | Annual reports | 152 | Mar 28, 2024 |
6-k | Quarterly Reports | 1 | Mar 13, 2024 |
6-k | Quarterly Reports | 1 | Feb 29, 2024 |
6-k | Quarterly Reports | 1 | Feb 12, 2024 |